CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		42,338,898
Beginning balance at Dec. 31, 2021	$ 271,786	$ 5	$ 389,408	$ (560)	$ (117,067)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)		39,616
Exercise of stock options and purchases pursuant to employee stock purchase plan	134		134
Stock-based compensation expense	1,513		1,513
Unrealized gain on investments	33			33
Net loss	(24,528)				(24,528)
Ending balance (in shares) at Mar. 31, 2022		42,378,514
Ending balance at Mar. 31, 2022	248,938	$ 5	391,055	(527)	(141,595)
Beginning balance (in shares) at Dec. 31, 2022		42,390,586
Beginning balance at Dec. 31, 2022	176,157	$ 5	396,041	(877)	(219,012)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)		11,888
Exercise of stock options and purchases pursuant to employee stock purchase plan	$ 39		39
Issuance of common stock upon settlement of restricted stock units (in shares)		73,937
Shares withheld related to net share settlement (in shares)	(16,153)
Shares withheld related to net share settlement	$ (39)		(39)
Stock-based compensation expense	1,683		1,683
Unrealized gain on investments	538			538
Net loss	(20,724)				(20,724)
Ending balance (in shares) at Mar. 31, 2023		42,460,258
Ending balance at Mar. 31, 2023	$ 157,654	$ 5	$ 397,724	$ (339)	$ (239,736)